Jaber Ebne Hayyan Pharmaceutical Company () engages in manufacture and sale of injection and oral antibiotics, ointments, inhalers, nasal sprays & pearls (soft gel capsules). The company was formerly known as Squibb Iran and changed its name in 1979. Jaber Ebne Hayyan Pharmaceutical Company was founded in 1960 and is based in Tehran, Iran. The company is public joint stock and member of Tehran Stock Exchange with the registered capital of 378,000,000,000 rials.
Products Ampicillin 250 mg, 500 mg & 1 g vial Cefazolin 250 mg, 500 mg & 1 g vial Cefotaxime 500 mg & 1 g vial Ceftriaxone 500 mg, 1 g & 2 g vial Vancomycin 500 mg & 1 g vial Nystatin 100000 U vag tab Cefixime 200 mg & 400 mg tab Cefalexin 250 mg & 500 mg cap Ibuprofen 200 mg & 400 mg pearl Salbutamol 100 mcg/doseE HFA inhaler Fluticasone 125 & 250 mcg/dose HFA inhaler Cromolyn 2% 13 mL nasal spray Calcitonin 100 & 200 IU/dose nasal spray
See also Iranian pharmaceutical industry
References Comprehensive DataBase Of All Listed Companies (Jaber Ebne Hayyan Pharma)
Iran pharmaceutical drug statistics (annual report) Iran Food and Drug Organization
External links Jaber Ebne Hayyan Pharmaceutical Company - Tehran Stock Exchange Official site